ArticleOPEN ACCESS

Pharmacological and clinical profile of ipragliflozin (Suglat®): A new therapeutic agent for type 2 diabetes

Folia Pharmacologica Japonica
DOI: 10.1254/fpj.145.36
5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Takasu, T., Takakura, S., & Kaku, S. (2015, January 10). Pharmacological and clinical profile of ipragliflozin (Suglat®): A new therapeutic agent for type 2 diabetes. Folia Pharmacologica Japonica. Japanese Pharmacological Society. https://doi.org/10.1254/fpj.145.36

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free